National Nov 12, 2021
Takeda applies for approval of Moderna's booster shots in Japan
A government subcommittee of health experts will discuss the use of the vaccine as a booster shot in late December at the earliest.
National Sep 7, 2021
Known as TAK-019 in Japan, the vaccine has proved to be 90% effective in preventing infections at clinical trials held abroad.
National / Science & Health Sep 7, 2021
Third man in Japan died after receiving recalled Moderna vaccine
The 49-year-old man, who was allergic to buckwheat, received his second shot on Aug. 11 and his death was confirmed the following day.
National Sep 2, 2021
Moderna to recall COVID-19 doses in Japan over stainless steel contaminants
The health ministry said particles of stainless steel were found in suspended Moderna COVID-19 vaccines, but it did not expect they would pose an additional health risk.
National / Science & Health May 23, 2021
Japan clinical trial of COVID-19 plasma therapy highlights slow-moving medical policy
by Osamu Tsukimori
Doctors are gearing up for clinical trials of convalescent plasma therapy, but many overseas hospitals have already moved on to other remedies.
National Mar 5, 2021
Japan's Takeda seeks government approval for Moderna COVID-19 vaccine
While awaiting regulatory approval, Takeda plans to start distributing the Moderna vaccine in the first half of this year.
National Mar 2, 2021
Moderna and Takeda to seek COVID-19 vaccine approval in Japan
The request, which could come as early as Friday, will be the third such application for regulatory approval.
National / Science & Health Feb 24, 2021
Takeda starts clinical trial of Novavax COVID-19 vaccine in Japan
The drugmaker said it expects to gain results from a study on 200 Japanese participants age 20 or older in the second half of this year.
National / Science & Health Oct 29, 2020
Takeda plans to supply 50 million doses of Moderna vaccine in Japan
Takeda Pharmaceutical Co. said Thursday it plans to supply 50 million doses of a coronavirus vaccine, developed by U.S. drugmaker Moderna Inc., in Japan from the first half of next year. The Japanese drugmaker said it will provide the vaccine based on a three-way agreement ...
Business / Corporate Aug 24, 2020
Takeda Pharmaceutical Co. agreed to sell its Japanese consumer health care business for ¥242 billion ($2.3 billion) to Blackstone Group Inc., which plans to take the over-the-counter medication unit public in about five years. For the drugmaker, the sale could represent one of the last ...
Business Aug 19, 2020
Takeda on track to sell OTC drug unit to Blackstone for ¥300 billion
Takeda is aiming to reduce debts after its purchase of Irish drugmaker Shire in January last year, the largest-ever Japanese acquisition of a foreign company.